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Significant and weak positive correlation was found between ADC and 
ve (median r=0.205, range [-0.01 0.39]) as well as ADC and RSI90 
(r=0.155 [0.02 0.25]) in 7 out of the 8 patients. ADC versus Ktrans, vp, 
and ABrix showed no systematic positive or negative correlation with 
median and range of the Pearson correlation being: -0.025[-0.18 
0.32], -0.06[-0.19 0.38] and0.015[-0.04 0.26], respectively.  
Conclusions: The positive correlation between ADC and ve can partly 
be explained by considering that extracellular diffusion is higher than 
intracellular diffusion. Since ve is a measure of the extracellular 
extravascular volume fraction a positive correlation with ADC was 
expected. In other words, the water molecules are able to traverse a 
greater distance resulting in a greater ADC value when the space not 
occupied by cells or vessels (ve) is high. However, in median, only 4% 
of the variation in ADC can be explained by ve. Similarly, RSI90 only 
explains in median 2.4% of the variation in ADC for this population. 
Inhomogeneities in the static B0-field may lead to distortions of the 
ADC maps. These B0-field correction was not taken into account in the 
analysis and may influence the correlation between ADC and 
perfusion-parameters. The time between the DW-MRI and the DCE-MRI 
is around 20 min and in this time the correlations may be deteriorated 
by motion and changes in the microenvironment of the tumor. To 
conclude, it may be said that DW-MRI and the DCE-MRI are mainly 
supplying complementary information about the tumor micro-
environment.  
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Purpose/Objective: There is a clinical need for a functional imaging 
technique sensitive to tumour characteristics that gives 
radiosensitivity information (hypoxia, proliferative ability and 
angiogenesis). We investigated the use of nanoparticles (NPs) as a 
contrast agent for tumour characteristics; NPs can be functionalised 
with antibodies that enable cellular uptake via specific cellular 
receptors, thus acting as biomarkers for tumour characteristics. We 
present a technique that enables simultaneous imaging of multiple 
biomarkers and could potentially be extended to imaging bulk 3D 
volumes. 
Materials and Methods: We have devised an x-ray fluorescence (XRF) 
technique capable of imaging NP concentration. The novel XRF 
imaging module consisted of a focussing polycapillary optic coupled to 
an energy resolving silicon drift detector. Proof of concept imaging to 
distinguish two component metals was undertaken; a phantom 
consisting of gold and tantalum wires was constructed and imaged. 
Demonstration of sensitivity to NP uptake in cells was performed; this 
involved NP cellular uptake experiments with colorectal cancer cells 
(HT29) and stromal cells (fibroblasts 3T3) using varying incubation 
concentrations of 1.9 nm gold NPs. The NP loaded cells were nested in 
collagen type 1 to construct 3D in vitro cancer models to demonstrate 
the sensitivity of the XRF technique to NP concentration and 
distribution. 
Results: The technique demonstrated ability to distinguish two metal 
types in imaging mode. XRF imaging was performed of several slices of 
the 3D cancer model (with a challenging GNP concentration ratio of 
5:1 between the tumour mass (0.7 million HT29) and surrounding) and 
all component details could be clearly seen, with a delineated tumour 
mass emitting at 5x more than the surrounding cellular stroma (Fig 1). 
The XRF signal was linear with NP concentration down to GNP 
concentrations of 1ppm. 
 
  
Figure 1 Gold XRF image of 3D artificial cancer mass with gold NP 
inclusions 
 
Conclusions: XRF imaging techniques can be used to image the 
distribution and concentration of NPs at concentrations typically 
found in NP loaded tumours. The technique can also be used to 
discriminate between NPs of different metals, suggesting potential for 
multiple biomarkers to be imaged simultaneously. Further work on 
functionalising NPs is required.  
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Purpose/Objective: QA for IMRT and VMAT has evolved substantially. 
In recent years, various commercial 2D and 3D ionization chamber or 
diode detector arrays have become commercially available, allowing 
for absolute dose verification with near real time results. This has led 
to a wide uptake to replace point dose and film dosimetry and to 
facilitate QA streamlining. However, arrays are limited by their spatial 
resolution which may affect the sensitivity of the gamma index 
analysis. The purpose of this study was to compare the sensitivity of 
the gamma index analysis (γ) in the Delta4®, ArcCHECK®, PTW 2D-
Array seven29™ and Octavius II™ phantom combination, Gafchromic® 
EBT2 and composite Varian Portal Dosimetry EPID measurements. 
Materials and Methods: To evaluate the γsensitivity of the different 
systems, errors were designed with deliberate changes of 1, 2, 5mm 
introduced into prostate and head & neck IMRT and RapidArc™plans 
throughout all control points in all fields for one 5mm MLC leaf. 
Collimator rotation errors of 1, 2, and 5° were introduced into a 
prostate & pelvic nodes RapidArc plan. The errors were designed to 
test each system. The expected gamma index pass rate was simulated 
by exporting the normal plan predicted dose and the calculated dose 
for each error plan. The predicted γ was calculated in Verisoft v5, 
OmniPro I’mRT v7, Delta4 software, SNC Patient v6, Portal Dosimetry 
v10, and averaged. Measurements were evaluated against the 
unperturbed dose distribution calculated using Varian Eclipse™ in the 
relevant phantom. In all cases, global γ was used with a 20% threshold 
relative to a point selected in a high dose and low gradient region. 
Various criteria for γ were analysed, including the commonly used 
3%/3mm criteria. The γ based on measurement was compared against 
the predicted to evaluate the sensitivity of each system. The 
concordance correlation coefficient, ρc, was used to assess statistical 
agreement. 
Results: There was good agreement between the predicted γ from 
each software (all ρc>0.93 relative to the average prediction). A 
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summary of mean and minimum percentage of detectors/pixels 
passing with γ<1 is given in Table 1 for 3%/3mm, 3%/2mm and 
2%/2mm for each system. A lower number indicates greater 
measurement sensitivity. Additionally, ρc, is given for the comparison 
between measured and predicted γ for each system in Table 1. The 
Delta4 was found to be the most sensitive system overall but with the 
lowest ρc, indicating lower agreement with the predicted γ. The 
remaining systems had comparable sensitivity to each other. The 2D-
Array and ArcCHECK measurements exhibited better statistical 
agreement with the predicted γ.  
Conclusions: It is important to understand the sensitivity and 
limitations of the gamma index analysis combined with the equipment 
in use. For the same passing criteria, different devices and software 
combinations exhibit varying sensitivity and agreement with the 
predicted analysis.  
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Purpose/Objective: The use of volumetric arc therapy (VMAT) is 
growing rapidly for many radio-therapy treatments due to its ability to 
quickly deliver highly conformal dose distributions. There has also 
been an increasing interest to use high dose rate flattening filter free 
(FFF) beams as inverse planning systems do not require flat, evenly 
distributed beams. Such fast and complex treatments should be 
accompanied by robust verification. Methods to calibrate electronic 
portal imaging device (EPID) dosimetry has been previously 
documented for step and shoot stereotactic treatments such as 
Intensity modulated radiotherapy (IMRT) using only flattened beams 
and only on the integrated fraction or beam. The aim of this work is 
to provide a time-dependent dose verification method for VMAT that 
can be used with flattened or FFF pre-treatment beams via a general 
calibration model for amorphous silicon (a-Si) EPIDs. 
Materials and Methods: The general calibration model was created 
using a Varian Truebeam, equipped with an as1000 EPID, for each 
unique energy spectrum 6MV, 10MV, 6MV-FFF, 10MV-FFF taking the 
field size, off axis ratio, and penumbral spectral changes of the beam 
into account. Also included in the model are the EPID specific 
corrections such as pixel sensitivity, support arm back scatter, and 
image ghosting. As planned VMAT treatments are separated into 
control points (CPs) for optimization, measured images are also 
separated into the same time intervals so that direct verification of 
prediction images can be performed. Linac log files were used to 
synchronize measurement and prediction. The dosimetric accuracy of 
the calibration model was determined for a range of treatment 
conditions. Measured and predicted 2D control point doses were 
compared using a gamma evaluation with criterion of 3% 3mm. 
Results: Out of 20 VMAT plans tested that passed the clinical action 
level for integrated dose (95% in field area with gamma within 3% 
3mm), the poorest performing plan contained 4.2% in-field area failing 
the gamma criterion when delivered with a flattened beam and 4.0% 
when delivered with a FFF beam. The same plan analysed per control 
point revealed that 18%, and 17% of the arc contained failure areas 
larger than 5% when delivered with a flattened and FFF beam 
respectively. Analysing VMAT treatments per control point reveals 
deviations from predictions during the arc that are averaged in 
integrated doses, and therefore undetectable. For repeated deliveries 
of the same plan, the highest dose variation in delivery of FFF plans 
was ~0.5% compared to 0.2% for flattened beams.  
 
 
Conclusions: The EPID calibration model allows verification of pre-
treatment VMAT doses for both flattened and unflattened beams in a 
time-dependent manner.  
 
OC-0156   
Pre-treatment verification of VMAT dose delivery as a function of 
gantry angle using EPID 
H. Woodruff1, T. Fuangrod2, E. van Uytven3, B.M.C. McCurdy3, P. 
Rowshanfarzad1, P.B. Greer4 
1University of Newcastle, Mathematical and Physical Sciences, 
Newcastle, Australia  
2University of Newcastle, School of Engineering, Newcastle, Australia  
3CancerCare Manitoba, Division of Medical Physics, Winnipeg, Canada  
4Calvary Mater Newcastle, Radiation Oncology, Newcastle, Australia  
 
Purpose/Objective: To develop a method for pre-treatment 
verification of VMAT dose delivery as a function of gantry angle using 
an EPID. 
Materials and Methods: The method: 1) compares MV EPID image 
frames with predicted images at the delivered gantry angles; 2) uses 
an accurate physics-based model that models the EPID images from 
the planned MLC motions and gantry angles; 3) acquires EPID image 
frames using an ancillary frame-grabber system that captures all 
acquired image frames without frame loss; 4) determines the gantry 
angle for the MV image from an accurate encoder-derived gantry 
angle tagged to the header of kV frames (acquired simultaneously 
with the frame-grabber); 5) accounts for small variations in delivered 
gantry angle by a search of a small sub-arc of angles centred on the 
imaged angle to synchronise the measured and predicted images; and 
6) performs Chi comparison of measured and predicted images giving 
these analyses as a function of gantry angle. The method also 
classifies images without significant signal due to beam-holds from 
low signal images using the scatter signal to the kV imager, and we 
have optimised the acquisition frame-rate to reduce image artefact 
due to beam pulse dropping during VMAT delivery. 
Results: The physics-based model was tested for agreement with EPID 
images integrated over the entire treatment with average Chi pass 
rates at 2%,2mm of 99.2% (10% threshold). The accuracy of the gantry 
angle method was tested using images of a phantom to encode the 
true angle on the MV image, with agreement (1 SD) of 0.1 degrees. Chi 
analysis results as a function of angle were assessed for 10 prostate 
patient deliveries. Approximately 650 images were captured during 
each arc delivery, resulting in ~ 100 Chi maps, each representing a 3.5 
degree sub-arc. All Chi pass-rates were greater than 90% at 3%,3mm 
criteria for these images, and more than 90% have a 95% pass-rate, 
  
 
 
 
 
 
 
 
 
 
 
 
 
